Tumorsphere assay provides more accurate prediction of in vivo responses to chemotherapeutics

Biotechnology Letters

Volumn 36, Issue 3, 2014, Pages 481-488

  Kim, Soyoung ^a   Alexander, Caroline M ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Breast tumor cells; Chemoresistance; Doxorubicin; High throughput screening; Paclitaxel; Quiescence; Sphere culture system; Tumorsphere

Indexed keywords

CYTOLOGY; CYTOTOXICITY; MONOLAYERS; SPHERES; STEM CELLS; TUMORS;

BREAST TUMOR CELLS; CHEMORESISTANCE; CULTURE SYSTEMS; DOXORUBICIN; HIGH-THROUGHPUT SCREENING; PACLITAXEL; QUIESCENCE; TUMORSPHERE;

DIAGNOSIS;

ANTINEOPLASTIC AGENT; DOXORUBICIN; PACLITAXEL;

ARTICLE; CELL CULTURE; CULTURE TECHNIQUE; DRUG SCREENING; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY;

ANTINEOPLASTIC AGENTS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; DOXORUBICIN; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; PACLITAXEL;

EID: 84897065805     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-013-1393-1     Document Type: Article

References (23)

1. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988.
2. Badders NM, Goel S, Clark RJ, Klos KS, Kim S, Bafico A, Lindvall C, Williams BO, Alexander CM (2009) The Wnt receptor, Lrp5, is expressed by mouse mammary stem cells and is required to maintain the basal lineage. PLoS ONE 4: e6594.
3. Blagosklonny MV, Fojo T (1999) Molecular effects of paclitaxel: myths and reality (a critical review). Int J Cancer 83: 151-156.
4. Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P, Narod SA (2007) Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 13: 4429-4434.
5. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ, Wicha MS (2003) In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17: 1253-1270.
6. Farnie G, Clarke RB, Spence K, Pinnock N, Brennan K, Anderson NG, Bundred NJ (2007) Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways. J Natl Cancer Inst 99: 616-627.
7. Gamucci T, D'Ottavio AM, Magnolfi E, Barduagni M, Vaccaro A, Sperduti I, Moscetti L, Belli F, Meliffi L (2007) Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer. Br J Cancer 97: 1040-1045.
8. Greaves M, Maley CC (2012) Clonal evolution in cancer. Nature 481: 306-313.
9. Grimshaw MJ, Cooper L, Papazisis K, Coleman JA, Bohnenkamp HR, Chiapero-Stanke L, Taylor-Papadimitriou J, Burchell JM (2008) Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells. Breast Cancer Res 10(3): R52. doi: 10. 1186/bcr2106.
10. Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA, Lander ES (2009) Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138: 645-659. doi: 10. 1186/bcr2106.
11. Haffty BG, Yang Q, Reiss M, Kearney T, Higgins SA, Weidhaas J, Harris L, Hait W, Toppmeyer D (2006) Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol 24: 5652-5657.
12. Kim S, Roopra A, Alexander CM (2012) A phenotypic mouse model of basaloid breast tumors. PLoS ONE 7: e30979.
13. Liu JC, Deng T, Lehal RS, Kim J, Zacksenhaus E (2007) Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors. Cancer Res 67: 8671-8681.
14. Montales MT, Rahal OM, Kang J, Rogers TJ, Prior RL, Wu X, Simmen RC (2012) Repression of mammosphere formation of human breast cancer cells by soy isoflavone genistein and blueberry polyphenolic acids suggests diet-mediated targeting of cancer stem-like/progenitor cells. Carcinogenesis 33: 652-660.
15. Pastrana E, Silva-Vargas V, Doetsch F (2011) Eyes wide open: a critical review of sphere-formation as an assay for stem cells. Cell Stem Cell 8: 486-498.
16. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA, Daidone MG (2005) Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65: 5506-5511.
17. Reynolds BA, Weiss S (1992) Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255: 1707-1710.
18. Rouzier R, Rajan R, Wagner P, Hess KR, Gold DL, Stec J, Ayers M, Ross JS, Zhang P, Buchholz TA, Kuerer H, Green M, Arun B, Hortobagyi GN, Symmans WF, Pusztai L (2005) Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer. Proc Natl Acad Sci USA 102: 8315-8320.
19. Schwartz MA (1997) Integrins, oncogenes, and anchorage independence. J Cell Biol 139: 575-578.
20. Shaw FL, Harrison H, Spence K, Ablett MP, Simoes BM, Farnie G, Clarke RB (2012) A detailed mammosphere assay protocol for the quantification of breast stem cell activity. J Mammary Gland Biol Neoplasia 17: 111-117.
21. Sledge GW, Neuberg D, Bernardo P, Ingle JN, Martino S, Rowinsky EK, Wood WC (2003) Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193). J Clin Oncol 21: 588-592.
22. Tirino V, Desiderio V, Paino F, De Rosa A, Papaccio F, La Noce M, Laino L, De Francesco F, Papaccio G (2013) Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization. FASEB J 27: 13-24.
23. Uchida Y, Tanaka S, Aihara A, Adikrisna R, Yoshitake K, Matsumura S, Mitsunori Y, Murakata A, Noguchi N, Irie T, Kudo A, Nakamura N, Lai PB, Arii S (2010) Analogy between sphere forming ability and stemness of human hepatoma cells. Oncol Rep 24: 1147-1151.